Results 11 to 20 of about 54,528 (266)

Potential predictive biomarker for diabetic peripheral neuropathy: serum neuron-specific enolase

open access: yesCurrent Issues in Pharmacy and Medical Sciences, 2023
The early stages of diabetic peripheral neuropathy (DPN) are symptomless. A reliable dependable and sensitive biomarker is needed for the purpose of early identification of diabetic peripheral neuropathy.
Majeed Islam Fareed   +3 more
doaj   +1 more source

Diabetic peripheral polyneuropathy in the practice of a primary care physician

open access: yesЛечащий Врач, 2021
Diabetic peripheral sensorimotor neuropathy is one of the most common complications of diabetes mellitus. Diagnosis of diabetic peripheral neuropathy consists of symptom assessment and clinical neurologic examination using quantitative tests to assess ...
E. Yu. Komelyagina, M. B. Antsiferov
doaj   +1 more source

Clinical Significance of the Presence of Autonomic and Vestibular Dysfunction in Diabetic Patients with Peripheral Neuropathy [PDF]

open access: yesDiabetes & Metabolism Journal, 2012
BackgroundWe investigated the prevalence of diabetic autonomic neuropathy (DAN) and vestibular dysfunction (VD) in diabetic patients with peripheral neuropathy.MethodsThirty-five diabetic patients with peripheral neuropathy were enrolled from August 2008
Soo Kyoung Kim   +10 more
doaj   +1 more source

Relation between Serum Uric Acid and Peripheral Neuropathy in Cases of Type 2 Diabetes Mellitus [PDF]

open access: yesInternational Journal of Medical Arts, 2023
Background: Peripheral neuropathy is a common sequel of diabetes mellitus type 2, and may occur as an initial manifestation of diabetes. The role of uric acid in diabetic neuropathy as a microvascular complication of diabetes type 2 has been reported in ...
Hossam Ali, Ahmed Al-Adl
doaj   +1 more source

Screening for diabetic peripheral neuropathy in resource-limited settings

open access: yesDiabetology & Metabolic Syndrome, 2023
Background Diabetic neuropathy is the most common microvascular complication of diabetes mellitus and a major risk factor for diabetes-related lower-extremity complications.
Ken Munene Nkonge   +2 more
doaj   +1 more source

Contemporary management of pain in cirrhosis: Toward precision therapy for pain

open access: yesHepatology, EarlyView., 2022
Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman   +4 more
wiley   +1 more source

Clinical effectiveness and treatment satisfaction between two triple‐therapy regimens in treating neuropathic pain: A real‐world data

open access: yesIbrain, EarlyView., 2023
This study compared the clinical effectiveness and treatment satisfaction of Pregabalin and Gabapentin triple therapy for neuropathic pain in a real‐world setting. The primary outcome measured the reduction in mean Self‐Administered Leeds Assessment of Neuropathic Symptoms and Signs pain score value from baseline to 12 weeks posttreatment.
Nithya Raju   +7 more
wiley   +1 more source

High resolution ultrasonography of the tibial nerve in diabetic peripheral neuropathy

open access: yesJournal of Ultrasonography, 2017
Aim of the study: High-resolution ultrasonography of the tibial nerve is a fast and non invasive tool for diagnosis of diabetic peripheral neuropathy. Our study was aimed at finding out the correlation of the cross sectional area and maximum thickness ...
Kunwarpal Singh   +2 more
doaj   +1 more source

Interactions between and Shared Molecular Mechanisms of Diabetic Peripheral Neuropathy and Obstructive Sleep Apnea in Type 2 Diabetes Patients

open access: yesJournal of Diabetes Research, 2018
Type 2 diabetes (T2D) accounts for about 90% of all diabetes patients and incurs a heavy global public health burden. Up to 50% of T2D patients will eventually develop neuropathy as T2D progresses.
Hong Shen   +3 more
doaj   +1 more source

A comparative study of Botulinum toxin type A versus conventional oral therapy as a second-line treatment of diabetic neuropathy

open access: yesThe Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2022
Background Diabetes mellitus is commonly complicated by diabetic peripheral neuropathy. Poor adherence to medication is common in diabetic peripheral neuropathy mainly due to common side effects and poor tolerance to medication.
Dina Elsayed Gaber, Hany M. El Deeb
doaj   +1 more source

Home - About - Disclaimer - Privacy